When it comes to the new gene-editing therapy known as CRISPR, the scientific community appears to be divided. While its applications for disease prevention are encouraging, the ethical implications and the unknown repercussions related to individual health remain a serious concern.
But where do the patients stand when it comes to the use of gene-editing therapy?
According to representatives from various patient advocacy organizations, the jury is still out on whether this technology is really a positive thing. People are still concerned about getting more information in order to make the proper choices.
“We’re a long way from a final opinion on any of these issues,” says Richard Hynes, a cancer researcher and co-chair of the national committee from Massachusetts Institute of Technology. “[It’s a] a discussion, not a finalization of opinions.”
To move the discussion forward, the medical community needs to learn more about the technology and base decisions on facts, not fear of the unknown.
No comments:
Post a Comment